Infex Therapeutics

Infex Therapeutics is a leader in the field of critical priority infectious diseases, with a broad and diverse pipeline of innovative first-in-class and best-in-class drug candidates aimed at addressing the urgent global shortage of novel anti-infective therapies. The company is building a differentiated pipeline through internal drug discovery, acquisitions, co-development, and the licensing of early/preclinical stage candidates, advancing them to clinical proof-of-concept before out-licensing to commercial pharmaceutical partners.